Seema Verma, President Trump’s pick to run the US Medicare agency, told the Senate Finance Committee that rural areas should not have to comply with CMS’ medical supplies competitive-bidding program if it is not a good fit. Verma was also questioned on changes she might make to the Affordable Care Act and the Medicare program, but did not offer many specifics.
Seema Verma, Trump’s nominee to head the US Medicare and Medicaid reimbursement agency, CMS, revealed very little about what changes she might make to those programs, but did caution that the agency needs to take care that its competitive-bidding program for medical suppliers does not impact beneficiary access, or cut providers out.
“A federal, one-size-fits-all approach doesn’t always work,” Verma said before the Senate Finance Committee at her Feb. 16 confirmation hearing....
Thena Capital, the first UK-based early-stage specialist medtech firm, has made its first investment since closing its £50m fund. Medtech Insight spoke with general partner Pamela Walker Geddes to gain insight into Thena Capital’s investment strategy.
An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.
HHS and its agencies violated the law by swiftly implementing “sweeping and poorly thought-through directives that ordered the bulk removal of healthcare resources,” including FDA draft guidances on diversity action plans and sex differences in clinical trials, a federal court said.
